Semin Neurol. 2001 Jun;21(2):131-9.

Amyotrophic lateral sclerosis: pathogenesis.

Source

Department of Neurology, University of Leuven School of Medicine, University Hospital Gasthuisberg, Belgium.

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating paralytic disorder caused by motor neuron degeneration. A subgroup of familial cases arises from mutations in the gene encoding cytosolic superoxide dismutase (SOD1). This review considers insight now being gained into ALS pathogenesis from the study of mutant SOD1 protein and its possible mechanisms of adverse effect on nerve cells. Also discussed are the status of other genetic forms of ALS and the elusive question of why this disorder so specifically targets motor neurons. Ultimately, it is hoped that insights from these types of studies will improve the prospects for developing meaningful therapies of ALS.

PMID:: 11442322; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice. [J Neurosci. 2008]
Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice.
Jaarsma D, Teuling E, Haasdijk ED, De Zeeuw CI, Hoogenraad CC. J Neurosci. 2008 Feb 27; 28(9):2075-88.
Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. [J Neurosci. 2001]
Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease.
Nagai M, Aoki M, Miyoshi I, Kato M, Pasinelli P, Kasai N, Brown RH Jr, Itoyama Y. J Neurosci. 2001 Dec 1; 21(23):9246-54.
Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. [Ann Neurol. 2007]
Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, Kwong LK, Forman MS, Ravits J, Stewart H, et al. Ann Neurol. 2007 May; 61(5):427-34.
Review Molecular biology of amyotrophic lateral sclerosis: insights from genetics. [Nat Rev Neurosci. 2006]
Review Molecular biology of amyotrophic lateral sclerosis: insights from genetics.
Pasinelli P, Brown RH. Nat Rev Neurosci. 2006 Sep; 7(9):710-23.
Review Genetics of amyotrophic lateral sclerosis. [Hum Mol Genet. 1996]
Review Genetics of amyotrophic lateral sclerosis.
Siddique T, Deng HX. Hum Mol Genet. 1996; 5 Spec No:1465-70.

See reviews... See all...

Cited by 8 PubMed Central articles

Melittin restores proteasome function in an animal model of ALS. [J Neuroinflammation. 2011]
Melittin restores proteasome function in an animal model of ALS.
Yang EJ, Kim SH, Yang SC, Lee SM, Choi SM. J Neuroinflammation. 2011 Jun 20; 8:69. Epub 2011 Jun 20.
Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models. [J Neuroinflammation. 2010]
Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models.
Yang EJ, Jiang JH, Lee SM, Yang SC, Hwang HS, Lee MS, Choi SM. J Neuroinflammation. 2010 Oct 15; 7:69. Epub 2010 Oct 15.
Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated VAP-B(P56S) neurotoxicity. [J Biol Chem. 2010]
Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated VAP-B(P56S) neurotoxicity.
Kim S, Leal SS, Ben Halevy D, Gomes CM, Lev S. J Biol Chem. 2010 Apr 30; 285(18):13839-49. Epub 2010 Mar 5.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Amyotrophic lateral sclerosis: pathogenesis.
Amyotrophic lateral sclerosis: pathogenesis.
Semin Neurol. 2001 Jun ;21(2):131-9.

PubMed
A systematic overview of chemotherapy effects in breast cancer.
A systematic overview of chemotherapy effects in breast cancer.
Acta Oncol. 2001 ;40(2-3):253-81.

PubMed
Knowledge: insufficient for change.
Knowledge: insufficient for change.
J Palliat Med. 2001 Summer ;4(2):145-7.

PubMed
Analysis of polymorphic regions of Plasmodium vivax Duffy binding protein of Kor...
Analysis of polymorphic regions of Plasmodium vivax Duffy binding protein of Korean isolates.
Korean J Parasitol. 2001 Jun ;39(2):143-50.

PubMed
The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on...
The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety.
Transfus Med Rev. 2001 Apr ;15(2 Suppl 1):45-59.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: